Genelux Corp. (GNLX)
2.24
+0.24
(+12.00%)
USD |
NASDAQ |
Nov 18, 16:00
2.24
0.00 (0.00%)
After-Hours: 19:20
Genelux Price to Book Value : 11.10 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 9.913 |
| November 16, 2026 | 9.516 |
| November 13, 2026 | 9.244 |
| November 12, 2026 | 9.417 |
| November 11, 2026 | 9.318 |
| November 10, 2026 | 9.665 |
| November 09, 2026 | 10.26 |
| November 06, 2026 | 9.714 |
| November 05, 2026 | 9.021 |
| November 04, 2026 | 9.714 |
| November 03, 2026 | 9.516 |
| November 02, 2026 | 9.913 |
| October 30, 2026 | 10.31 |
| October 29, 2026 | 10.41 |
| October 28, 2026 | 10.95 |
| October 27, 2026 | 10.16 |
| October 26, 2026 | 9.467 |
| October 23, 2026 | 9.913 |
| October 22, 2026 | 9.814 |
| October 21, 2026 | 10.26 |
| October 20, 2026 | 12.39 |
| October 19, 2026 | 12.14 |
| October 16, 2026 | 11.99 |
| October 15, 2026 | 12.29 |
| October 14, 2026 | 11.50 |
| Date | Value |
|---|---|
| October 13, 2026 | 12.49 |
| October 12, 2026 | 12.61 |
| October 09, 2026 | 12.69 |
| October 08, 2026 | 12.39 |
| October 07, 2026 | 12.49 |
| October 06, 2026 | 12.59 |
| October 05, 2026 | 12.89 |
| October 02, 2026 | 12.69 |
| October 01, 2026 | 12.49 |
| September 30, 2026 | 12.54 |
| September 29, 2026 | 6.858 |
| September 28, 2026 | 6.914 |
| September 25, 2026 | 6.942 |
| September 24, 2026 | 6.802 |
| September 23, 2026 | 7.040 |
| September 22, 2026 | 7.306 |
| September 21, 2026 | 7.166 |
| September 18, 2026 | 7.082 |
| September 17, 2026 | 7.082 |
| September 16, 2026 | 6.55 |
| September 15, 2026 | 6.914 |
| September 14, 2026 | 7.110 |
| September 11, 2026 | 6.970 |
| September 10, 2026 | 6.942 |
| September 09, 2026 | 7.054 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.221 |
| Alnylam Pharmaceuticals, Inc. | 5.553 |
| Anika Therapeutics, Inc. | 1.326 |
| Savara, Inc. | 9.024 |
| Arrowhead Pharmaceuticals, Inc. | 121.09 |
Price to Book Value Related Metrics
| PS Ratio | 12048.72 |
| PEG Ratio | -3.837 |
| Price | 2.24 |
| Earnings Yield | -39.51% |
| Market Cap | 101.03M |
| PEGY Ratio | -3.837 |